Jennifer Altomonte

Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats.

Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse.

Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes.

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice.

Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats.

Elevated vascular endothelial growth factor production in islets improves islet graft vascularization.

Foxo1 mediates insulin action on apoC-III and triglyceride metabolism.

Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance.

PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1.

Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.

Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver.

Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo.

rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3.

Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats.

Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor aminoguanidine (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat.

Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.

Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma.

Surgeon Yurii Voronoy (1895-1961) - a pioneer in the history of clinical transplantation: in memoriam at the 75th anniversary of the first human kidney transplantation.

Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.

Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.

Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses.

Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125.

Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.

Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.

PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.

Characterization of magnetic viral complexes for targeted delivery in oncology.

Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib.